25 XP   0   0   10

IO Biotech Inc
Buy, Hold or Sell?

Let's analyse IO Biotech Inc together

PenkeI guess you are interested in IO Biotech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of IO Biotech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about IO Biotech Inc

I send you an email if I find something interesting about IO Biotech Inc.

Quick analysis of IO Biotech Inc (30 sec.)










What can you expect buying and holding a share of IO Biotech Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.02
Expected worth in 1 year
$1.68
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.35
Return On Investment
-22.3%

For what price can you sell your share?

Current Price per Share
$1.55
Expected price per share
$1.07 - $1.85
How sure are you?
50%

1. Valuation of IO Biotech Inc (5 min.)




Live pricePrice per Share (EOD)

$1.55

Intrinsic Value Per Share

$-18.07 - $-21.57

Total Value Per Share

$-16.05 - $-19.55

2. Growth of IO Biotech Inc (5 min.)




Is IO Biotech Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$133.1m$138.8m-$5.6m-4.3%

How much money is IO Biotech Inc making?

Current yearPrevious yearGrowGrow %
Making money-$86m-$71.4m-$14.6m-17.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of IO Biotech Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#329 / 1007

Most Revenue
#581 / 1007

Most Profit
#713 / 1007

Most Efficient
#755 / 1007

What can you expect buying and holding a share of IO Biotech Inc? (5 min.)

Welcome investor! IO Biotech Inc's management wants to use your money to grow the business. In return you get a share of IO Biotech Inc.

What can you expect buying and holding a share of IO Biotech Inc?

First you should know what it really means to hold a share of IO Biotech Inc. And how you can make/lose money.

Speculation

The Price per Share of IO Biotech Inc is $1.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of IO Biotech Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in IO Biotech Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.02. Based on the TTM, the Book Value Change Per Share is $-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of IO Biotech Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.31-84.3%-1.31-84.3%-1.08-70.0%-0.79-50.9%-0.79-50.9%
Usd Book Value Change Per Share-0.09-5.6%-0.09-5.6%-1.11-71.6%0.4026.1%0.4026.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.09-5.6%-0.09-5.6%-1.11-71.6%0.4026.1%0.4026.1%
Usd Price Per Share1.88-1.88-2.30-2.12-2.12-
Price to Earnings Ratio-1.44--1.44--2.12--1.84--1.84-
Price-to-Total Gains Ratio-21.76--21.76--2.07--7.38--7.38-
Price to Book Ratio0.93-0.93-1.09-0.80-0.80-
Price-to-Total Gains Ratio-21.76--21.76--2.07--7.38--7.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.55
Number of shares645
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.090.40
Usd Total Gains Per Share-0.090.40
Gains per Quarter (645 shares)-55.73260.74
Gains per Year (645 shares)-222.911,042.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-223-233010431033
20-446-456020862076
30-669-679031293119
40-892-902041724162
50-1115-1125052155205
60-1337-1348062586248
70-1560-1571073017291
80-1783-1794083448334
90-2006-2017093879377
100-2229-224001043010420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.04.00.020.0%1.04.00.020.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.05.00.0%0.00.05.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.04.00.020.0%1.04.00.020.0%

Fundamentals of IO Biotech Inc

About IO Biotech Inc

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.

Fundamental data was last updated by Penke on 2024-04-21 23:29:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of IO Biotech Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit IO Biotech Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare IO Biotech Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IO Biotech Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--218.5%+218.5%
YOY--282.4%+282.4%
5Y--432.2%+432.2%
10Y--593.8%+593.8%
1.1.2. Return on Assets

Shows how efficient IO Biotech Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare IO Biotech Inc to the Biotechnology industry mean.
  • -57.1% Return on Assets means that IO Biotech Inc generated $-0.57 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IO Biotech Inc:

  • The MRQ is -57.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -57.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-57.1%TTM-57.1%0.0%
TTM-57.1%YOY-47.1%-10.0%
TTM-57.1%5Y-92.5%+35.3%
5Y-92.5%10Y-92.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-57.1%-13.2%-43.9%
TTM-57.1%-12.6%-44.5%
YOY-47.1%-11.5%-35.6%
5Y-92.5%-13.7%-78.8%
10Y-92.5%-15.5%-77.0%
1.1.3. Return on Equity

Shows how efficient IO Biotech Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare IO Biotech Inc to the Biotechnology industry mean.
  • -64.6% Return on Equity means IO Biotech Inc generated $-0.65 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IO Biotech Inc:

  • The MRQ is -64.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -64.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-64.6%TTM-64.6%0.0%
TTM-64.6%YOY-51.5%-13.2%
TTM-64.6%5Y-29.6%-35.0%
5Y-29.6%10Y-29.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-64.6%-16.7%-47.9%
TTM-64.6%-15.8%-48.8%
YOY-51.5%-14.4%-37.1%
5Y-29.6%-19.0%-10.6%
10Y-29.6%-19.9%-9.7%

1.2. Operating Efficiency of IO Biotech Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient IO Biotech Inc is operating .

  • Measures how much profit IO Biotech Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare IO Biotech Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IO Biotech Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.5%+286.5%
TTM--229.1%+229.1%
YOY--288.4%+288.4%
5Y--480.7%+480.7%
10Y--624.7%+624.7%
1.2.2. Operating Ratio

Measures how efficient IO Biotech Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of IO Biotech Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.307-3.307
YOY-3.774-3.774
5Y-5.667-5.667
10Y-7.558-7.558

1.3. Liquidity of IO Biotech Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if IO Biotech Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.37 means the company has $9.37 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of IO Biotech Inc:

  • The MRQ is 9.369. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.369. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.369TTM9.3690.000
TTM9.369YOY13.883-4.514
TTM9.3695Y9.497-0.128
5Y9.49710Y9.4970.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3693.890+5.479
TTM9.3694.182+5.187
YOY13.8835.343+8.540
5Y9.4976.135+3.362
10Y9.4976.453+3.044
1.3.2. Quick Ratio

Measures if IO Biotech Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare IO Biotech Inc to the Biotechnology industry mean.
  • A Quick Ratio of 9.18 means the company can pay off $9.18 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IO Biotech Inc:

  • The MRQ is 9.182. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.182. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.182TTM9.1820.000
TTM9.182YOY13.500-4.317
TTM9.1825Y9.172+0.011
5Y9.17210Y9.1720.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1823.528+5.654
TTM9.1824.059+5.123
YOY13.5005.390+8.110
5Y9.1726.138+3.034
10Y9.1726.488+2.684

1.4. Solvency of IO Biotech Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of IO Biotech Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare IO Biotech Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12 means that IO Biotech Inc assets are financed with 11.6% credit (debt) and the remaining percentage (100% - 11.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IO Biotech Inc:

  • The MRQ is 0.116. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.116. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.116TTM0.1160.000
TTM0.116YOY0.085+0.031
TTM0.1165Y2.198-2.082
5Y2.19810Y2.1980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1160.339-0.223
TTM0.1160.337-0.221
YOY0.0850.273-0.188
5Y2.1980.368+1.830
10Y2.1980.391+1.807
1.4.2. Debt to Equity Ratio

Measures if IO Biotech Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare IO Biotech Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 13.2% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IO Biotech Inc:

  • The MRQ is 0.132. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.132. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.132TTM0.1320.000
TTM0.132YOY0.093+0.039
TTM0.1325Y0.055+0.077
5Y0.05510Y0.0550.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1320.388-0.256
TTM0.1320.403-0.271
YOY0.0930.342-0.249
5Y0.0550.432-0.377
10Y0.0550.461-0.406

2. Market Valuation of IO Biotech Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings IO Biotech Inc generates.

  • Above 15 is considered overpriced but always compare IO Biotech Inc to the Biotechnology industry mean.
  • A PE ratio of -1.44 means the investor is paying $-1.44 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IO Biotech Inc:

  • The EOD is -1.186. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.439. Based on the earnings, the company is expensive. -2
  • The TTM is -1.439. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.186MRQ-1.439+0.253
MRQ-1.439TTM-1.4390.000
TTM-1.439YOY-2.120+0.682
TTM-1.4395Y-1.836+0.398
5Y-1.83610Y-1.8360.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.186-2.249+1.063
MRQ-1.439-2.553+1.114
TTM-1.439-2.669+1.230
YOY-2.120-4.107+1.987
5Y-1.836-6.247+4.411
10Y-1.836-6.499+4.663
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of IO Biotech Inc:

  • The EOD is -1.417. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.719. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.719. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.417MRQ-1.719+0.302
MRQ-1.719TTM-1.7190.000
TTM-1.719YOY-2.508+0.789
TTM-1.7195Y-2.912+1.193
5Y-2.91210Y-2.9120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.417-2.858+1.441
MRQ-1.719-3.288+1.569
TTM-1.719-3.552+1.833
YOY-2.508-5.560+3.052
5Y-2.912-8.326+5.414
10Y-2.912-8.881+5.969
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of IO Biotech Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.93 means the investor is paying $0.93 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of IO Biotech Inc:

  • The EOD is 0.767. Based on the equity, the company is cheap. +2
  • The MRQ is 0.930. Based on the equity, the company is cheap. +2
  • The TTM is 0.930. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.767MRQ0.930-0.163
MRQ0.930TTM0.9300.000
TTM0.930YOY1.091-0.161
TTM0.9305Y0.802+0.128
5Y0.80210Y0.8020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.7671.929-1.162
MRQ0.9302.090-1.160
TTM0.9302.091-1.161
YOY1.0912.881-1.790
5Y0.8023.545-2.743
10Y0.8023.936-3.134
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of IO Biotech Inc.

3.1. Institutions holding IO Biotech Inc

Institutions are holding 81.129% of the shares of IO Biotech Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vivo Capital, LLC9.37060.9503617343900
2023-12-31Novo A/S8.72340.6672574706700
2023-12-31Samsara BioCapital, LLC5.52511.0646364001500
2023-12-31Morgan Stanley - Brokerage Accounts3.46330.0004228168222128693215.7717
2023-12-31Marshall Wace Asset Management Ltd3.19560.0067210526200
2023-12-31Armistice Capital, LLC2.92040.04941924000-224000-10.4283
2023-12-31Bank of America Corp2.79930.00041844185-10000-0.5393
2023-12-31Stonepine Capital Management Llc2.52891.35461666037-309271-15.6568
2023-09-30Partner Fund Management LP2.05440.08991353453740740120.8951
2023-09-30Alyeska Investment Group, L.P.1.49920.00959876549876540
2023-12-31Pivotal bioVenture Partners Investment Advisor LLC1.31180.412186419700
2023-12-31Logos Global Management LP0.74960.086749382700
2023-12-31Bridgeway Capital Management, LLC0.22040.0059145200130009.8336
2023-12-31Renaissance Technologies Corp0.13490.00038890064514264.5534
2023-12-31Geode Capital Management, LLC0.019301273000
2023-12-31UBS Group AG0.017011204112040
2023-12-31Wealth Enhancement Advisory Services, LLC0.01520.000110000-100-0.9901
2023-12-31Comerica Bank00220
2023-12-31Ancora Advisors LLC000-908-100
2023-09-30Citadel Advisors Llc000-37690-100
Total 44.54844.698129348854+3448014+11.7%

3.2. Funds holding IO Biotech Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31HBM Healthcare Investments AG Ord5.98730.3714394449200
2023-12-31Bridgeway Ultra-Small Company Market0.22040.1469145200130009.8336
2024-02-29Fidelity Nasdaq Composite Index0.0380.00032504000
Total 6.24570.51864114732+13000+0.3%

3.3. Insider Transactions

Insiders are holding 2.954% of the shares of IO Biotech Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-09Holdings A/s NovoSELL6588091.5
2023-11-21Brian BurkavageBUY50000.99
2023-08-09Vivo Capital Ix, LlcBUY31578941.9

4. Summary

4.1. Key Performance Indicators

The key performance indicators of IO Biotech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.086-0.0860%-1.109+1184%0.404-121%0.404-121%
Book Value Per Share--2.0212.0210%2.108-4%1.291+57%1.291+57%
Current Ratio--9.3699.3690%13.883-33%9.497-1%9.497-1%
Debt To Asset Ratio--0.1160.1160%0.085+37%2.198-95%2.198-95%
Debt To Equity Ratio--0.1320.1320%0.093+41%0.055+141%0.055+141%
Dividend Per Share----0%-0%-0%-0%
Eps---1.307-1.3070%-1.085-17%-0.788-40%-0.788-40%
Free Cash Flow Per Share---1.094-1.0940%-0.917-16%-0.583-47%-0.583-47%
Free Cash Flow To Equity Per Share---0.003-0.0030%1.930-100%1.015-100%1.015-100%
Gross Profit Margin--0.9910.9910%1.000-1%0.998-1%0.998-1%
Intrinsic Value_10Y_max---21.568--------
Intrinsic Value_10Y_min---18.067--------
Intrinsic Value_1Y_max---1.156--------
Intrinsic Value_1Y_min---1.124--------
Intrinsic Value_3Y_max---4.240--------
Intrinsic Value_3Y_min---3.991--------
Intrinsic Value_5Y_max---8.247--------
Intrinsic Value_5Y_min---7.510--------
Market Cap102115395.000-21%123856092.000123856092.0000%151526070.000-18%139403984.400-11%139403984.400-11%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.767-21%0.9300.9300%1.091-15%0.802+16%0.802+16%
Pe Ratio-1.186+18%-1.439-1.4390%-2.120+47%-1.836+28%-1.836+28%
Price Per Share1.550-21%1.8801.8800%2.300-18%2.116-11%2.116-11%
Price To Free Cash Flow Ratio-1.417+18%-1.719-1.7190%-2.508+46%-2.912+69%-2.912+69%
Price To Total Gains Ratio-17.940+18%-21.760-21.7600%-2.074-90%-7.376-66%-7.376-66%
Quick Ratio--9.1829.1820%13.500-32%9.172+0%9.172+0%
Return On Assets---0.571-0.5710%-0.471-18%-0.925+62%-0.925+62%
Return On Equity---0.646-0.6460%-0.515-20%-0.296-54%-0.296-54%
Total Gains Per Share---0.086-0.0860%-1.109+1184%0.404-121%0.404-121%
Usd Book Value--133162000.000133162000.0000%138854000.000-4%85021200.000+57%85021200.000+57%
Usd Book Value Change Per Share---0.086-0.0860%-1.109+1184%0.404-121%0.404-121%
Usd Book Value Per Share--2.0212.0210%2.108-4%1.291+57%1.291+57%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.307-1.3070%-1.085-17%-0.788-40%-0.788-40%
Usd Free Cash Flow---72060000.000-72060000.0000%-60419000.000-16%-38425000.000-47%-38425000.000-47%
Usd Free Cash Flow Per Share---1.094-1.0940%-0.917-16%-0.583-47%-0.583-47%
Usd Free Cash Flow To Equity Per Share---0.003-0.0030%1.930-100%1.015-100%1.015-100%
Usd Market Cap102115395.000-21%123856092.000123856092.0000%151526070.000-18%139403984.400-11%139403984.400-11%
Usd Price Per Share1.550-21%1.8801.8800%2.300-18%2.116-11%2.116-11%
Usd Profit---86083000.000-86083000.0000%-71458000.000-17%-49647400.000-42%-49647400.000-42%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.086-0.0860%-1.109+1184%0.404-121%0.404-121%
 EOD+3 -5MRQTTM+0 -0YOY+6 -245Y+7 -2310Y+7 -23

4.2. Fundamental Score

Let's check the fundamental score of IO Biotech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.186
Price to Book Ratio (EOD)Between0-10.767
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than19.182
Current Ratio (MRQ)Greater than19.369
Debt to Asset Ratio (MRQ)Less than10.116
Debt to Equity Ratio (MRQ)Less than10.132
Return on Equity (MRQ)Greater than0.15-0.646
Return on Assets (MRQ)Greater than0.05-0.571
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of IO Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.470
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets150,718
Total Liabilities17,556
Total Stockholder Equity133,162
 As reported
Total Liabilities 17,556
Total Stockholder Equity+ 133,162
Total Assets = 150,718

Assets

Total Assets150,718
Total Current Assets147,255
Long-term Assets3,463
Total Current Assets
Cash And Cash Equivalents 143,193
Net Receivables 1,127
Other Current Assets 2,935
Total Current Assets  (as reported)147,255
Total Current Assets  (calculated)147,255
+/-0
Long-term Assets
Property Plant Equipment 3,106
Long-term Assets Other 89
Long-term Assets  (as reported)3,463
Long-term Assets  (calculated)3,195
+/- 268

Liabilities & Shareholders' Equity

Total Current Liabilities15,717
Long-term Liabilities1,839
Total Stockholder Equity133,162
Total Current Liabilities
Short-term Debt 655
Accounts payable 3,878
Other Current Liabilities 11,184
Total Current Liabilities  (as reported)15,717
Total Current Liabilities  (calculated)15,717
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,839
Long-term Liabilities  (as reported)1,839
Long-term Liabilities  (calculated)1,839
+/-0
Total Stockholder Equity
Common Stock66
Retained Earnings -263,822
Accumulated Other Comprehensive Income -9,669
Other Stockholders Equity 406,587
Total Stockholder Equity (as reported)133,162
Total Stockholder Equity (calculated)133,162
+/-0
Other
Capital Stock66
Cash and Short Term Investments 143,193
Common Stock Shares Outstanding 43,540
Liabilities and Stockholders Equity 150,718
Net Debt -140,699
Net Invested Capital 133,162
Net Working Capital 131,538
Property Plant and Equipment Gross 3,436
Short Long Term Debt Total 2,494



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-31
> Total Assets 
9,423
5,653
222,288
151,805
150,718
150,718151,805222,2885,6539,423
   > Total Current Assets 
9,403
5,635
221,738
148,219
147,255
147,255148,219221,7385,6359,403
       Cash And Cash Equivalents 
7,846
3,405
211,531
142,590
143,193
143,193142,590211,5313,4057,846
       Net Receivables 
1,233
1,500
2,091
1,533
1,127
1,1271,5332,0911,5001,233
       Inventory 
221
359
-2,091
-1,533
0
0-1,533-2,091359221
       Other Current Assets 
103
371
10,207
5,629
2,935
2,9355,62910,207371103
   > Long-term Assets 
20
18
550
3,586
3,463
3,4633,5865501820
       Property Plant Equipment 
0
0
155
3,234
3,106
3,1063,23415500
       Other Assets 
20
18
550
352
0
03525501820
> Total Liabilities 
32,954
40,956
10,364
12,951
17,556
17,55612,95110,36440,95632,954
   > Total Current Liabilities 
10,842
3,050
10,305
10,676
15,717
15,71710,67610,3053,05010,842
       Short-term Debt 
8,663
0
0
515
655
655515008,663
       Short Long Term Debt 
8,663
0
0
0
0
00008,663
       Accounts payable 
997
522
3,928
4,004
3,878
3,8784,0043,928522997
       Other Current Liabilities 
234
2,528
6,377
6,157
11,184
11,1846,1576,3772,528234
   > Long-term Liabilities 
22,112
37,906
59
2,275
1,839
1,8392,2755937,90622,112
       Capital Lease Obligations 
0
0
0
2,790
2,494
2,4942,790000
       Other Liabilities 
52
0
59
0
0
0059052
       Long-term Liabilities Other 
52
0
59
2,275
0
02,27559052
> Total Stockholder Equity
-23,531
-35,303
211,924
138,854
133,162
133,162138,854211,924-35,303-23,531
   Common Stock
28
28
29
29
66
6629292828
   Retained Earnings -263,822-177,739-106,281-38,402-26,360
   Accumulated Other Comprehensive Income 
1,297
1,961
-1,489
-10,141
-9,669
-9,669-10,141-1,4891,9611,297
   Capital Surplus 
0
0
0
326,705
0
0326,705000
   Treasury Stock00000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-756
Gross Profit-756-756
 
Operating Income (+$)
Gross Profit-756
Operating Expense-90,687
Operating Income-91,443-91,443
 
Operating Expense (+$)
Research Development67,829
Selling General Administrative24
Selling And Marketing Expenses-756
Operating Expense90,68767,097
 
Net Interest Income (+$)
Interest Income4,712
Interest Expense-3
Other Finance Cost-6
Net Interest Income4,715
 
Pretax Income (+$)
Operating Income-91,443
Net Interest Income4,715
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-85,231-97,655
EBIT - interestExpense = -91,446
-85,231
-86,080
Interest Expense3
Earnings Before Interest and Taxes (EBIT)-91,443-85,228
Earnings Before Interest and Taxes (EBITDA)-90,687
 
After tax Income (+$)
Income Before Tax-85,231
Tax Provision-1,486
Net Income From Continuing Ops-79,972-86,717
Net Income-86,083
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses91,443
Total Other Income/Expenses Net6,212-4,715
 

Technical Analysis of IO Biotech Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of IO Biotech Inc. The general trend of IO Biotech Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine IO Biotech Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of IO Biotech Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.5231 < 1.8453 < 1.85.

The bearish price targets are: 1.33 > 1.13 > 1.07.

Tweet this
IO Biotech Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of IO Biotech Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

IO Biotech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of IO Biotech Inc.

IO Biotech Inc Daily Moving Average Convergence/Divergence (MACD) ChartIO Biotech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of IO Biotech Inc. The current adx is .

IO Biotech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of IO Biotech Inc.

IO Biotech Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of IO Biotech Inc.

IO Biotech Inc Daily Relative Strength Index (RSI) ChartIO Biotech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of IO Biotech Inc.

IO Biotech Inc Daily Stochastic Oscillator ChartIO Biotech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of IO Biotech Inc.

IO Biotech Inc Daily Commodity Channel Index (CCI) ChartIO Biotech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of IO Biotech Inc.

IO Biotech Inc Daily Chande Momentum Oscillator (CMO) ChartIO Biotech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of IO Biotech Inc.

IO Biotech Inc Daily Williams %R ChartIO Biotech Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of IO Biotech Inc.

IO Biotech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of IO Biotech Inc.

IO Biotech Inc Daily Average True Range (ATR) ChartIO Biotech Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of IO Biotech Inc.

IO Biotech Inc Daily On-Balance Volume (OBV) ChartIO Biotech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of IO Biotech Inc.

IO Biotech Inc Daily Money Flow Index (MFI) ChartIO Biotech Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for IO Biotech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

IO Biotech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of IO Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.470
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of IO Biotech Inc with someone you think should read this too:
  • Are you bullish or bearish on IO Biotech Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about IO Biotech Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about IO Biotech Inc

I send you an email if I find something interesting about IO Biotech Inc.


Comments

How you think about this?

Leave a comment

Stay informed about IO Biotech Inc.

Receive notifications about IO Biotech Inc in your mailbox!